Erythropoietin to treat anaemia in patients with head and neck cancer.

Lancet

Volumn 363, Issue 9402, 2004, Pages

  Leyland Jones, Brian ^a   Mahmud, Salaheddin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ANEMIA; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEAD AND NECK TUMOR; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE; RANDOMIZED CONTROLLED TRIAL; STANDARD; TREATMENT OUTCOME; DISEASE FREE SURVIVAL;

ANEMIA; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TREATMENT OUTCOME; DISEASE-FREE SURVIVAL; IRON;

MLCS; MLOWN;

EID: 1442307804     PISSN: None     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/s0140-6736(03)15185-9     Document Type: Note

References (0)